174 related articles for article (PubMed ID: 10465333)
1. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
3. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
4. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.
Ioachim E; Assimakopoulos D; Goussia AC; Peschos D; Skevas A; Agnantis NJ
Histol Histopathol; 1999 Oct; 14(4):1113-8. PubMed ID: 10506927
[TBL] [Abstract][Full Text] [Related]
6. PCNA and P53 expression in relation to clinicopathological features of oral papilloma.
Sulkowska M; Famulski W; Stasiak-Barmuta A; Kasacka I; Koda M; Chyczewski L; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():193-4. PubMed ID: 11820603
[TBL] [Abstract][Full Text] [Related]
7. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
[TBL] [Abstract][Full Text] [Related]
9. Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia.
Izawa H; Yonemitsu N; Shin T; Sugihara H
Auris Nasus Larynx; 1999 Jul; 26(3):317-30. PubMed ID: 10419041
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological comparison of the World Health Organization (WHO) and Ljubljana classifications on the grading of preneoplastic lesions of the larynx.
Sengiz S; Pabuççuoğlu U; Sarioğlu S
Pathol Res Pract; 2004; 200(3):181-8. PubMed ID: 15200269
[TBL] [Abstract][Full Text] [Related]
11. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions.
Peschos D; Damala C; Stefanou D; Tsanou E; Assimakopoulos D; Vougiouklakis T; Charalabopoulos K; Agnantis NJ
Histol Histopathol; 2006 Jun; 21(6):603-8. PubMed ID: 16528670
[TBL] [Abstract][Full Text] [Related]
13. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor, c-erbB-2 and p53 overexpressions in epithelial hyperplastic lesions of the larynx.
Gale N; Zidar N; Kambic V; Poljak M; Cör A
Acta Otolaryngol Suppl; 1997; 527():105-10. PubMed ID: 9197495
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.
Sousa FA; Paradella TC; Carvalho YR; Rosa LE
J Oral Sci; 2009 Mar; 51(1):117-21. PubMed ID: 19325208
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic activity is increased in parallel with the metaplasia-dysplasia-carcinoma sequence of the bronchial epithelium.
Törmänen U; Nuorva K; Soini Y; Pääkkö P
Br J Cancer; 1999 Feb; 79(5-6):996-1002. PubMed ID: 10070903
[TBL] [Abstract][Full Text] [Related]
17. From epithelial dysplasia to squamous carcinoma of the head and neck region: evolutive and prognostic histopathological markers.
Silvestri F; Bussani R; Pavletic N; Mannone T; Bosatra A
Acta Otolaryngol Suppl; 1997; 527():49-51. PubMed ID: 9197481
[TBL] [Abstract][Full Text] [Related]
18. Can p53 nuclear over-expression, Bcl-2 accumulation and PCNA status be of prognostic significance in high-risk superficial and invasive bladder tumours?
Plastiras D; Moutzouris G; Barbatis C; Presvelos V; Petrakos M; Theodorou C
Eur J Surg Oncol; 1999 Feb; 25(1):61-5. PubMed ID: 10188857
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of p27 is correlated with progression in precancerous lesions of the larynx.
Hirai T; Hayashi K; Takumida M; Ueda T; Hirakawa K; Yajin K
Auris Nasus Larynx; 2003 May; 30(2):163-8. PubMed ID: 12753988
[TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]